|
Examples of projects listed by our key areas of specialist pharmaceutical technical expertise:
Research and early development
Product licensing
Regulatory affairs
Clinical development
Pharmacovigilance
Investigator brochure
Resource management and outsourcing
Training and staff development
Research and early development
| Issues: |
| |
Poorly defined work processes and decision-making
regarding evaluation of in-house generated candidate drugs meant that
transition into clinical development was slow and inefficient. |
| Objectives: |
| |
Improve the quality and consistency of the in-house
generation and evaluation of candidate drugs and support their transition
into early clinical development. |
| Services: |
| |
Analyse current process and define new, improved process.
|
| |
Produce supporting documentation to aid staff and
decision-makers. |
| |
Centralise information in a user-friendly intranet
site to support implementation of the improved process. |
| Benefit: |
| |
Clearly defined interface between Research and Development,
including defined roles and responsibilities, and standardised documentation. |
| |
Globally communicated and understood process receiving
appropriate input and resources from other relevant departments including
Marketing and Production |
| |
Concise decision-making information, go/no-go
criteria and formally recorded decisions. |
Back to top 
Product licensing
| Issues: |
| |
Product in-licensing was key to the company strategy
but evaluations took too long and were very resource intensive. |
| |
Decision-making lacked transparency, objectivity and
was inadequately recorded thus making company learning difficult.
|
| |
A lack of consistency in the evaluation process, The
evaluation process lacked consistency and there was inadequate supporting
documentation. |
| Objectives: |
| |
Improve the quality and the consistency of the in-licensing
evaluation process. |
| Services: |
| |
Review the current process and design improvement
opportunities. |
| |
Produce checklists and templates to support both evaluators
and decision-makers. |
| |
Centralise information in a user-friendly intranet
site to support implementation. |
| Benefit: |
| |
In-licensing evaluation 30% quicker with decreased
resource burden. |
| |
Concise decision-making information available with
defined go/no-go criteria and formally recorded decisions.
|
Back to top 
Regulatory affairs
| Issues: |
| |
The Regulatory Affairs (RA) function was decentralised
and geographically dispersed. |
| |
It was considered beneficial to centralise the function
but without loosing the regional expertise required to maintain the
large and diverse product portfolio. |
| Objectives: |
| |
Recommend the most effective and efficient processes
and organisation for global and national RA to optimally support the
companys business objectives. |
| Services: |
| |
Analyse current RA practice, develop processes that
best meet customers needs then design the organisation which best
supports these processes. |
| |
Support the implementation of the new global RA process
and organisation. |
| Benefit: |
| |
A re-engineered global RA process and organisation. |
| |
RA process and geographical specialisation introduced
into the organisational structure to optimally support the business. |
| |
Harmonised working practices and a more stable critical
mass of expertise. |
Back to top 
Clinical development
| Issues: |
| |
Recent centralisation of the Clinical function meant
that there was little continuity or consistency of clinical processes.
The department was overworked and underskilled, with poor quality
of outsourced trials. |
| Scope: |
| |
Develop a two-year clinical operations strategic plan
to build an efficient, effective and quality-focused department. |
| Services: |
| |
Collect relevant data, information and map the departments
processes. |
| |
Analyse data including GAP analysis using industry
best practice and metrics for equivalent environment. |
| |
Prepare 2-year strategic plan and department vision
and mission |
| Benefit: |
| |
Excellent buy-in for the plan from management and
staff. |
| |
Rapid implementation of the plan resulting in increased
level of quality and efficiency. |
Back to top 
Pharmacovigilance
| Issues: |
| |
Fragmented and inefficient Pharmacovigilance (PV)
function. |
| |
Potential risks resulting from sub-optimal handling
of safety information |
| Scope: |
| |
Assessment and analysis of risks of international
PV function. |
| Services: |
| |
Data collection, collation and analysis; functional
risk assessment. |
| |
Recommendations for process and organisational improvements
to minimise risks |
| Benefit: |
| |
Recommendations accepted by senior management and
implemented with assistance of Calcis Consulting. |
| |
Risks identified and a risk management plan put in
place leading to improved quality and efficiency of the process. |
Back to top 
Investigator brochure
| Issues: |
| |
There were issues with Investigator Brochure (IB)
quality and coordination problems between Medical Writers and Project
Teams across sites in the US and Europe. |
| |
Input of numerous functions required for IB development
and maintenance, however the process was inefficient and poorly understood
by stakeholders. |
| Objectives: |
| |
Improve the IB process across the company in terms
of stakeholder understanding and buy-in, process efficiency and IB
quality. |
| Services: |
| |
Review and clarify the international IB process and
suggest improvement opportunities. |
| |
Produce a user-friendly IB process intranet site to
centralise process information, documentation and templates, learning
and best-practice and links to relevant external information. |
| Benefit: |
| |
Process clarified and efficiency improved. IB process
intranet site produced and live within three months. |
| |
Positive feedback from customers on significantly
improved IB quality. |
| |
On-line process support approach rapidly taken up
by other R&D functions. |
Back to top 
Resource management and outsourcing
| Issues: |
| |
The aggressive company growth strategy required a
significant increase in investment in product development resource
¯ but the most suitable resource model for the company required
definition. |
| Objectives: |
| |
Recommend the most efficient product development resource
model to support the companys business objectives including
an integrated outsourcing strategy. |
| Services: |
| |
Given the group strategy, redefine core competencies
and activities, conduct workload and resource modelling and assess
potential outsourcing partners. |
| |
Develop an integrated resource and outsourcing strategy
and support processes. |
| Benefit: |
| |
An integrated resource and outsourcing strategy making
optimal use of current resource with the allocation of budget for
strategic outsourcing. |
Back to top 
Training and staff development
| Issues: |
| |
Internal and external audit findings suggested that
Clinical training could be significantly improved. SOP compliance,
understanding and interpretation were variable across different countries. |
| Scope: |
| |
International clinical SOP training strategy and programme. |
| |
Developing and delivering innovative SOP training
courses. |
| Services: |
| |
Training strategy, planning and delivery of innovative
interactive training courses on company SOPs. |
| |
Delivery of train the trainer programme
for internal project management teams. |
| Result: |
| |
Over 100 people trained successfully, courses received
very high scores on evaluation; number of courses and training audience
expanded. |
| |
Client set up SOP review and revision forum following the success
of training. |
Back to top 
|